David Curiel, MD, PhD, professor of radiation oncology, and Washington University in St. Louis graduate student Paul Boucher have been awarded an R01 grant from the NIH for $6.5M over 5 years. Their research entitled “Vectored HIV Immunotherapy via in vivo B cell editing” aims to elicit broadly neutralizing antibodies against HIV through in vivo CRISPR/Cas engineering of the B cell receptor.